![Steve Nowicki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steve Nowicki
Corporate Officer/Principal at Fresenius Kabi Pharmaceuticals Holding LLC
Steve Nowicki active positions
Companies | Position | Start | End |
---|---|---|---|
Fresenius Kabi Pharmaceuticals Holding LLC
![]() Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 2011-03-01 | - |
Career history of Steve Nowicki
Former positions of Steve Nowicki
Companies | Position | Start | End |
---|---|---|---|
CARDINAL HEALTH, INC. | Corporate Officer/Principal | - | - |
Training of Steve Nowicki
North Carolina State University | Graduate Degree |
Purdue University | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
Private companies | 1 |
---|---|
Fresenius Kabi Pharmaceuticals Holding LLC
![]() Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Steve Nowicki
- Experience